Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Raj, K; Eikema, DJ; McLornanl, DP; Olavarria, E; Bloke, HJ; Bregante, S; Ciceri, F; Passweg, J; Ljungman, P; Schaap, N; Carlson, K; Zuckerman, T; de Wreede, LC; Volin, L; Koc, Y; Diez-Martin, JL; Brossart, P; Wolf, D; Blaise, D; Di Bartolomeo, P; Vitek, A; Robin, M; Yakoub-Agha, I; Chalandon, Y; Kroger, N.

Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2019; 25(3): 522-528 Nº de citas: 48 [doi:10.1016/j.bbmt.2018.10.017]

Osorio, S; Escudero-Vilaplana, V; Reguilon-Gallego, L; Gomez-Centurion, I; Diez, JL; Ferrer-Marin, F.

Severe liver toxicity in a chronic myeloid leukemia patient probably induced by a drug interaction between imatinib and sertraline

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2019; 25(2): 484-486 Nº de citas: 3 [doi:10.1177/1078155217735689]

Gonzalez-Rincon, J; Mendez, M; Gomez, S; Garcia, JF; Martin, P; Bellas, C; Pedrosa, L; Rodriguez-Pinilla, SM; Camacho, FI; Quero, C; Perez-Callejo, D; Rueda, A; Llanos, M; Gomez-Codina, J; Piris, MA; Montes-Moreno, S; Barcena, C; Rodriguez-Abreu, D; Menarguez, J; De la Cruz-Merino, L; Monsalvo, S; Parejo, C; Royuela, A; Kwee, I; Cascione, L; Arribas, A; Bertoni, F; Mollejo, M; Provencio, M; Sanchez-Beato, M.

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma

PLoS One. 2019; 14(2): Nº de citas: 38 [doi:10.1371/journal.pone.0212813]

Alonso, L; Gonzalez-Vicent, M; Belendez, C; Badell, I; Sastre, A; Rodriguez-Villa, A; Bermudez-Cortes, M; Hladun, R; de Heredia, CD.

Hematopoietic stem cell transplantation in pediatric patients with thalassemia and sickle cell disease: An experience of the Spanish Working Group for Bone Marrow Transplantation in Children (GETMON)

MEDICINA CLINICA. 2019; 152(4): 135-140 Nº de citas: 11 [doi:10.1016/j.medcli.2018.05.013]

Dreger, P; Sureda, A; Ahn, KW; Eapen, M; Litovich, C; Finel, H; Boumendil, A; Gopal, A; Herrera, AF; Schmid, C; Diez-Martin, JL; Fuchs, E; Bolanos-Meade, J; Gooptu, M; Al Malki, MM; Castagna, L; Ciurea, SO; Dominietto, A; Blaise, D; Ciceri, F; Tischer, J; Corradini, P; Montoto, S; Robinson, S; Gulbas, Z; Hamadani, M.

PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL

Blood Advances. 2019; 3(3): 360-369 Nº de citas: 91 [doi:10.1182/bloodadvances.2018027748]

Sahebi, F; Garderet, L; Kanate, AS; Eikema, DJ; Knelange, NS; Alvelo, OFD; Koc, Y; Blaise, D; Bashir, Q; Moraleda, JM; Dreger, P; Sanchez, JF; Ciurea, S; Schouten, H; Shah, NN; Verbeekl, M; Rosler, W; Diez-Martin, JL; Schoenland, S; D'Souza, A; Kroger, N; Hari, P.

Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2019; 25(2): 335-342 Nº de citas: 21 [doi:10.1016/j.bbmt.2018.09.018]

Fernandez-Cruz, A; Alba, N; Semiglia-Chong, MA; Padilla, B; Rodriguez-Macias, G; Kwon, M; Cercenado, E; Chamorro-de-Vega, E; Machado, M; Perez-Lago, L; de Viedma, DG; Martin, JLD; Munoz, P.

A Case-Control Study of Real-Life Experience with Ceftolozane-Tazobactam in Patients with Hematologic Malignancy and Pseudomonas aeruginosa Infection

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2019; 63(2): Nº de citas: 41 [doi:10.1128/AAC.02340-18]

Bazarbachi, A; Boumendil, A; Finel, H; Mohty, M; Castagna, L; Blaise, D; Peggs, KS; Afanasyev, B; Diez-Martin, JL; Corradini, P; Michonneau, D; Robinson, S; Gutierrez Garcia, G; Bonifazi, F; Yakoub-Agha, I; Gulbas, Z; Bloor, A; Delage, J; Esquirol, A; Malladi, R; Scheid, C; El-Cheikh, J; Ghesquieres, H; Montoto, S; Dreger, P; Sureda, A.

Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party

CANCER. 2019; 125(1): 90-98 Nº de citas: 13 [doi:10.1002/cncr.31755]

Hernandez-Boluda, JC; Pereira, A; Pastor-Galan, I; Alvarez-Larran, A; Savchuk, A; Puerta, JM; Sanchez-Pina, JM; Collado, R; Diaz-Gonzalez, A; Angona, A; Sagues, M; Garcia-Gutierrez, V; Boque, C; Osorio, S; Vallansot, R; Palomera, L; Mendizabal, A; Casado, LF; Perez-Encinas, M; Perez-Lopez, R; Ferrer-Marin, F; Sanchez-Guijo, F; Garcia, C; de las Heras, N; Lopez-Lorenzo, JL; Cervantes, F; Steegmann, JL; GELMC.

Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients

Blood Cancer Journal. 2018; 8: 91-91 Nº de citas: 41 [doi:10.1038/s41408-018-0125-0]

Sanchez, CA; Cancho, EJB; Garcia, AR; Mintegi, S; Pardillo, RM; Sanchez, CA; Cancho, EJB; Garcia, AR; Mintegi, S; Pardillo, RM; Fernandez, SM; Obieta, A; Chaves, N; Farres, C; Estopina, G; Panzino, FD; Benito, H; Gonzalez, L; Perez, MA; Rodriguez, A; Soc Espanola Urgencias Pediat.

Emergency department consultations associated with unintentional injuries: A cases series

ANALES DE PEDIATRIA. 2018; 89(6): 333-343 Nº de citas: 9 [doi:10.1016/j.anpedi.2018.02.003]

Mussetti, A; De Philippis, C; Carniti, C; Bastos-Oreiro, M; Gayoso, J; Cieri, N; Pennisi, M; Ciceri, F; Greco, R; Peccatori, J; Patriarca, F; Mariotti, J; Castagna, L; Corradini, P.

CD3+graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide

BONE MARROW TRANSPLANTATION. 2018; 53(12): 1522-1531 Nº de citas: 24 [doi:10.1038/s41409-018-0183-8]

Salgado, M; Kwon, M; Galvez, C; Badiola, J; Nijhuis, M; Bandera, A; Balsalobre, P; Miralles, P; Buno, I; Martinez-Laperche, C; Vilaplana, C; Jurado, M; Clotet, B; Wensing, A; Martinez-Picado, J; Diez-Martin, JL; IciStem Consortium.

Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant

ANNALS OF INTERNAL MEDICINE. 2018; 169(10): 674-683 Nº de citas: 59 [doi:10.7326/M18-0759]

Lobitz, S; Telfer, P; Cela, E; Allaf, B; Angastiniotis, M; Backman Johansson, C; Badens, C; Bento, C; Bouva, MJ; Canatan, D; Charlton, M; Coppinger, C; Daniel, Y; de Montalembert, M; Ducoroy, P; Dulin, E; Fingerhut, R; Frommel, C; Garcia-Morin, M; Gulbis, B; Holtkamp, U; Inusa, B; James, J; Kleanthous, M; Klein, J; Kunz, JB; Langabeer, L; Lapoumeroulie, C; Marcao, A; Soria, JLM; McMahon, C; Ohene-Frempong, K; Perini, JM; Piel, FB; Russo, G; Sainati, L; Schmugge, M; Streetly, A; Tshilolo, L; Turner, C; Venturelli, D; Vilarinho, L; Yahyaoui, R; Elion, J; Colombatti, R; European Reference Network.

Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference

BRITISH JOURNAL OF HAEMATOLOGY. 2018; 183(4): 648-660 Nº de citas: 101 [doi:10.1111/bjh.15600]

Canaani, J; Labopin, M; Huang, XJ; Ciceri, F; Van Lint, MT; Bruno, B; Santarone, S; Diez-Martin, JL; Blaise, D; Chiusolo, P; Wu, DP; Mohty, M; Nagler, A.

Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T-cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

BRITISH JOURNAL OF HAEMATOLOGY. 2018; 183(3): 411-420 Nº de citas: 26 [doi:10.1111/bjh.15540]

Rodriguez-Otero, P; Mateos, MV; Martinez-Lopez, J; Martin-Calvo, N; Hernandez, MT; Ocio, EM; Rosinol, L; Martinez, R; Teruel, AI; Gutierrez, NC; Bargay, J; Bengoechea, E; Gonzalez, Y; de Oteyza, JP; Gironella, M; Encinas, C; Martin, J; Cabrera, C; Palomera, L; de Arriba, F; Cedena, MT; Paiva, B; Puig, N; Oriol, A; Blade, J; Lahuerta, JJ; San Miguel, JF.

Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role

LEUKEMIA. 2018; 32(11): 2427-2434 Nº de citas: 9 [doi:10.1038/s41375-018-0072-6]

Santos, N; Rodriguez-Romanos, R; de la Camara, R; Brunet, S; Nieto, JB; Buno, I; Martinez, C; Jimenez-Velasco, A; Vallejo, C; Gonzalez, M; Solano, C; Ferra, C; Sampol, A; Perez-Simon, JA; Lopez-Jimenez, J; Diez, JL; Gallardo, D.

PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation

ANNALS OF HEMATOLOGY. 2018; 97(11): 2217-2224 Nº de citas: 10 [doi:10.1007/s00277-018-3438-y]

Osorio, S; Escudero-Vilaplana, V; Gomez-Centurion, I; Perez-Lopez, R; Ayala, R; Vall-Llovera, F; Garcia-Gutierrez, V; Casares, MTG; Miguel, JDGS; Hernandez-Rivas, JA; Sanchez-Guijo, F; Martinez-Garcia, AB; Villalon, L; Conesa-Garcia, V; Rodriguez, A; Casado, F; Garcia-Gonzalez, X; Perdomo, MNS; Banos, U; Steegmann, JL.

Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?

ANNALS OF HEMATOLOGY. 2018; 97(11): 2089-2098 Nº de citas: 20 [doi:10.1007/s00277-018-3413-7]

Gayoso, J; Balsalobre, P; Kwon, M; Herrera, P; Bermudez, A; Sampol, A; Jimenez, S; Lopez-Corral, L; Serrano, D; Pinana, JL; Pascual, MJ; Heras, I; Bento, L; Varela, R; Humala, K; Zabalza, A; Laiglesia, A; Bastos-Oreiro, M; Perez-Corral, A; Martinez-Laperche, C; Buno, I; Diez-Martin, JL.

Busulfan-based myeloablative conditioning regimens for haploidentical transplantation in high-risk acute leukemias and myelodysplastic syndromes

EUROPEAN JOURNAL OF HAEMATOLOGY. 2018; 101(3): 332-339 Nº de citas: 9 [doi:10.1111/ejh.13103]